Inventiva S.A.
- Close
- Oct 29, 2026 · +0.54%
- Market cap
- $720.77M
- 193.24M shares
- Filings
- 228
Q2 2025−47.4% FY24 yoy
Q2 2025N/M FY24 yoy
Q2 2025N/M FY24 yoy
—
—
—Q2 2025N/M FY24 yoy
Q2 2025+258.7% FY24 yoy
- $720.77M
- —
- —
- —
- —
- —
Price
Oct 29, 2026 · Official close
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2024 | 2024-12-31 | €9,198,000 | reported | |
| FY 2023 | 2023-12-31 | €17,477,000 | reported | |
| FY 2022 | 2022-12-31 | €12,179,000 | reported | |
| FY 2021 | 2021-12-31 | €4,194,000 | reported | |
| FY 2020 | 2020-12-31 | €372,000 | reported | |
| FY 2019 | 2019-12-31 | €6,998,000 | reported | |
| FY 2018 | 2018-12-31 | €3,197,000 | reported |
Segments
Geography
LineFY2022ShareChange
China€12.05M99%—
France€125.00K1.0%−35.6%
USA———
Total€12.18M
Pharmaceutical preparations
Inventiva S.A. is the 177th largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
GERNGeron Corp———$636.4MACRSAclaris Therapeutics, Inc.$7.8M58.2%829.6%$635.2MQNRXQuoin Pharmaceuticals Ltd.———$628.9MANNXAnnexon, Inc.———$625.8MWVEWave Life Sciences, Inc.$42.7M60.5%478.3%$622.3MABUSArbutus Biopharma Corp$14.1M128.2%237.9%$617.8M
IVAInventiva S.A. (this company)———$604.8M
EVOEvotec SE———$595.6MCAPRCapricor Therapeutics, Inc.$0.0100.0%—$595.1MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Inventiva S.A. · CIK 1756594 · Engraved from SEC EDGAR